EcoDrugPlus

Coagulation Factor Xi-Like

Ensembl ID : ENSPNAG00000010808
Gene Symbol: LOC108425187
2 Cross references
215 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSPNAG00000019110
Gene Symbol: CCDC6
4 Cross references
151 Possible Orthologues:

Coiled-Coil Domain-Containing Protein 6-Like

Ensembl ID : ENSPNAG00000026830
Gene Symbol: LOC108431652
3 Cross references
207 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSPNAG00000028880
Gene Symbol: LOC108433274
3 Cross references
287 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSPNAG00000005687
Gene Symbol: LOC108433251
3 Cross references
288 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSPNAG00000011099
Gene Symbol: CSF1R
3 Cross references
10 Possible Orthologues:

Complement C1s Subcomponent-Like

Ensembl ID : ENSPNAG00000000109
Gene Symbol: LOC108414193
2 Cross references
160 Possible Orthologues:

Complement C1s Subcomponent-Like

Ensembl ID : ENSPNAG00000000112
Gene Symbol: LOC108414195
2 Cross references
160 Possible Orthologues:

Complement C1s Subcomponent-Like

Ensembl ID : ENSPNAG00000020578
Gene Symbol: LOC108429008
2 Cross references
156 Possible Orthologues:

Complement Component 5

Ensembl ID : ENSPNAG00000024432
Gene Symbol: C5
2 Cross references
216 Possible Orthologues:

Complement Factor D-Like

Ensembl ID : ENSPNAG00000016324
Gene Symbol: LOC108421051
3 Cross references
133 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSPNAG00000012977
Gene Symbol: CRHR1
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).